Delivery of medicinal products under Appendix 2 of the Positive Drug List for the needs of DPB-Kardzhali
Titre original de l'avis
Bulgaria – Pharmaceutical products – „Доставка на лекарствени продукти по Приложение №2 на Позитивния лекарствен списък за нуждите на ДПБ-Кърджали“.
Score d'opportunité
Pourquoi ce score ?
Opportunité
35 / 100
Complexité
60 / 100
Facteurs de risque
Complex licensing requirements under Bulgarian pharmaceutical law. Foreign suppliers must obtain registration with the...
Narcotics license required for item 89; missing license could disqualify the entire bid if the lot cannot be split.
Restricted procedure — pre-qualification required
Analyse approfondie du portefeuille
Utilise:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Aperçu
Moderate opportunityFaits clés
- BGN 280k estimated value
- Dynamic Purchasing System (DPS)
- Supplies contract
- 1 lot
- Duration until Apr 2027
- Delivery of pharmaceutical products listed in Appendix 2 of the Positive Drug List (Bulgarian Positive Drug List) to the State Psychiatric Hospital in Kardzhali.
Afficher le résumé complet
This tender by the State Psychiatric Hospital - Kardzhali (Bulgaria) seeks a supplier for the delivery of medicinal products listed in Appendix 2 of the Positive Drug List. It is a restricted procedure under a Dynamic Purchasing System (DPS) with a single lot, valued at 280,000 BGN. The award is based solely on the lowest price. Contract duration is from April 2025 to April 2027. The tender is conducted in Bulgarian and requires specific pharmaceutical licenses, including a narcotics license for certain items. EU funding status is inconsistent (structured data indicates EU-funded, XML indicates no EU funds). Procurement documents were not analyzed.
Risques
Complex licensing requirements under Bulgarian pharmaceutical law. Foreign suppliers must obtain registration with the...
Narcotics license required for item 89; missing license could disqualify the entire bid if the lot cannot be split.
Restricted procedure — pre-qualification required
L'analyse peut être incomplète
Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.
Exigences clés
Technical
- Supplier must hold a valid wholesale distribution authorization, manufacturing authorization, or import authorization under the Bulgarian Medicinal Products in Human Medicine...
- Foreign suppliers must be registered with the Bulgarian Drug Agency (ИАЛ) to trade pharmaceuticals in Bulgaria.
Certifications
- For narcotic substances (nomenclature unit No. 89), supplier must hold a valid license under Article 32 of the Narcotic Substances and Precursors Control Act.
Les exigences peuvent être incomplètes.
Critères d'attribution
Lot 1
Acheteur
Localisation
гр.Кърджали, BGR
Site web
Profil acheteur
Identifiant
000234067
Activité
Health
Lots (1)
LOT-0001
Delivery of medicinal products under Appendix 2 of the Positive Drug List for the needs of DPB-Kardzhali
Supply of pharmaceutical products included in Appendix 2 of the Positive Drug List to the State Psychiatric Hospital - Kardzhali. The contract covers a period from 11 April 2025 to 11 April 2027. The lot includes a specific item (nomenclature unit No. 89) containing narcotic substances, requiring additional licensing.
BGN 280k
Valeur estimée
Localisation
Durée
Catégorie
Critères d'attribution
Date limite
Détails des critères
Най - ниска цена
Note sur la valeur
Afficher les données TED originales
Titre original du lot
„Доставка на лекарствени продукти по Приложение №2 на Позитивния лекарствен списък за нуждите на ДПБ-Кърджали“.
Description TED originale
Целта на обществената поръчка е да се удовлетвори нуждите на ДПБ - Кърджали от доставки на лекарствени продукти, които са включени в Приложение №2 на Позитивния лекарствен списък.
Détails de la procédure
- Date de publication
- 13 Apr 2025
- Langues
- Bulgarian
Métadonnées de référence
- Base juridique
- 32014L0024
Identifiants de référence
- ID de l'appel d'offres
- 241422-2025
Documents (1)
Appels d'offres similaires
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Denmark – Pharmaceutical products – Amgros 2027 1.1170.a
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta
Score d'opportunité
Pourquoi ce score ?
Opportunité
35 / 100
Complexité
60 / 100
Facteurs de risque
Complex licensing requirements under Bulgarian pharmaceutical law. Foreign suppliers must obtain registration with the...
Narcotics license required for item 89; missing license could disqualify the entire bid if the lot cannot be split.
Restricted procedure — pre-qualification required
Analyse approfondie du portefeuille
Utilise:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications